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Summary
Tricaine methane-sulfonate (MS-222) is one of the most widely
used anaesthetics for poikilotherms worldwide. This paper
outlines its anaesthetic eﬃcacy and dosage in ﬁsh and
legislation for its use, ﬁsh stress responses to MS-222 anaes-
thesia and its eﬀect on ﬁsh physiology and blood properties,
pharmacokinetics, genotoxicity, immune response, potential
interference with ﬁsh hepatic cytochrome P450 spectra, and its
impact on nerve sensitivity. Key questions arising from the
available data are analysed, such as regulatory constraints on
its use, the need for the standardization of buﬀering protocols,
and interdependencies of the factors impacting the speciﬁc
applicative eﬃcacy of MS-222. Current research has provided
an abundance of data on MS-222 use in ﬁsh, although the
applications within these studies are often impractical at the
farming level. Speciﬁc emphasis is therefore placed on high-
lighting application strategies on a practical basis, presenting
potential future research on topics that require in-depth
analysis (preparation and storage of anaesthetic solutions,
pre-anaesthetic sedation and stress reduction, cortisol response
in aquarium ﬁsh, toxicity of MS-222 metabolites, and possible
immunodepressive properties). Additionally, both from a
scientiﬁc andpractical perspective, it is necessary to have abetter
understanding of safety margins, induction, immersion and
recovery times for many (marine and freshwater, farmed and
ornamental) ﬁsh species in order to achieve optimal utilization.
Introduction
Anaesthesia, euthanasia and sedation of ﬁsh, both wild and
captive, are common practices and requirements in aquaculture
and experimental procedures. Tricaine methane-sulphonate
(MS-222), C9H11O2N + CH3SO3H, also known as ethyl
m-amino benzoate, tricaine mesilate, m-aminobenzoic acid
ethyl ester methanesulfonate andmetacaine, has been one of the
most widely used anaesthetic agents for poikilotherms world-
wide since its introduction in 1967. It was originally produced
as a local analgesic alternative to cocaine and has been used as
such in humans. However, its value as an anaesthetic for
aquatic animals was soon recognized and its further develop-
ment was exclusively for this purpose. Supplied as a white
crystalline powder as a 100% pure drug, it is intended for
dissolution in water; one advantage is a solubility to 11%,
forming a clear colourless acid solution. A very high lipid
solubility makes it suitable for use in both freshwater and
seawater (Brown, 1993; EMEA, 1999; Treves-Brown, 2000;
Ortuno et al., 2002; Coyle et al., 2004; Daniel, 2009; Maricch-
iolo and Genovese, 2011).
MS-222 is used for diverse routine operations such as the
selection of ﬁsh, sorting, grading, weight ⁄ length measure-
ments, sampling, labelling, transportation, broodstock anaes-
thesia, gamete collection, physiological data collection, blood
sampling, health monitoring, vaccination, radio transmitter
implanting and invasive surgery such as implantation of serial
sampling devices (e.g. cannulas, catheters) for the collection of
bile, blood and urine (Spaeth and Schweickert, 1977; Jennings
and Looney, 1998; Redman et al., 1998; McKim et al., 1999;
Tapper et al., 2000; Bowser, 2001; Wagner et al., 2003;
Lewbart et al., 2005; Cotter and Rodnick, 2006; Kiessling
et al., 2009; Weber et al., 2009; Brown et al., 2011). Intra-
arterial or tissue implantation of microdialysis probes also
requires the use of MS-222. Fish have been anaesthetised prior
to liver perfusion for the preparation of isolated hepatocytes
(Kolanczyk et al., 2003). MS-222 is widely used with larval
and ornamental ﬁsh to reduce transport stress, facilitate
handling and sorting, immobilise larvae for force-feeding,
study the role of muscular contraction in the development of
various skeletal pathologies, limit activity in metabolic studies
and for various surgical procedures (Guo et al., 1995; Massee
et al., 1995; Rombough, 2007; Kucuk, 2010; Pramod et al.,
2010). Aeration should be provided unless sedation or anaes-
thesia is of short duration. A controlled overdose is often used
for humanely euthanizing ﬁsh prior to the lethal sampling of
tissues or blood (Holloway et al., 2004; Sinclair, 2004; Wilson
et al., 2009).
The aim of this paper is to present a critical review of MS-
222 application in ﬁsh, its eﬃcacy and dosage, genotoxicity,
impact on ﬁsh physiology and blood properties, immune
response issues and ﬁsh stress responses, and to give an
overview of recent literature reports and advances in the ﬁeld
of ﬁsh pharmacology. Emphasis has been placed on highlight-
ing practical application strategies and potential future
research. Given the importance of sedating ﬁsh within the
context of ﬁsh welfare, there is a growing trend towards
exploring the diverse aspects and proper use of MS-222, which
has been compounded by the constraints of employing
veterinary medicinal products in the aquaculture industry.
Legal aspects
In recent decades, European legislation regarding veterinary
pharmaceuticals has introduced restrictions for use of medi-
cines in treatment of farm animals; as a result, available
veterinary medicinal products for ﬁsh are now authorised. The
main document regarding the availability of aquaculture
medicines is the regulation for the establishment of maximum
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residue limits (MRL) (CEC, 1990). In its Annex II, MS-222 is
authorised within the list of substances not subject to MRLs
designated for ﬁnﬁsh, for water-borne use only (CEC, 1990;
EMEA, 1999). However, in many European countries there is
no registered ﬁsh anaesthetic, and the list of pharmaceuticals
licensed for ﬁsh varies. For example, MS-222 is not licensed in
Spain, Greece or France, while it is permitted in the United
Kingdom (UK), Italy, Spain and Norway (EFSA, 2008;
Daniel, 2009). Some European countries have limitations
regarding the use of MS-222, such as Italy, where it is
approved only for vaccination and research purposes (EFSA,
2008). Countries exporting ﬁsh into the European Union (EU)
are required to demonstrate that they comply with the
respective EU regulations on the use and withdrawal of
anaesthetics. Therefore, potential MS-222 users within Europe
should consult their regional legislation prior to administra-
tion to ﬁsh. In the United States MS-222 is approved by the
U.S. Food and Drug Administration for use as a ﬁsh
anaesthetic, but only on Ictaluridae, Salmonidae, Esocidae
and Percidae (FDA, 2006). The recommended withdrawal time
of MS-222 varies among countries. For instance, the U.S.A.
and Norway have a 21-day withdrawal period before the ﬁsh
can be consumed. Canada requires a 5-day withdrawal period
for water temperatures above 10C (Wagner et al., 2002;
Western Chemical, 2008; Kiessling et al., 2009; AFS, 2011),
New Zealand 10 days (Ross and Ross, 2008), while in the UK
ﬁsh are deemed ﬁt for human consumption after 70 degree
days prior to the last MS-222 application (Pharmaq, 2010).
Although it is reported to be non-mutagenic (Yoshimura et al.,
1981; EMEA, 1999; Alpharma, 2001), care should be taken
regarding withdrawal if ﬁsh are intended for human consump-
tion, since MS-222 is regarded as carcinogenic (Pirhonen and
Schreck, 2003). MS-222 should be handled with caution, since
it may cause skin and respiratory tract irritation (Sigma, 2007).
It has also been reported to cause reversible retinal toxicity
related to chronic occupational exposure, requiring protective
clothing to avoid contact during use (Bernstein et al., 1997).
The additional legislative matters aﬀecting safety and methods
of use are important and are growing. Therefore, MS-222 users
are urged to follow through and adhere to all updated and
necessary regulations for the location in which they operate.
Buffering and storage
Some studies suggest that MS-222 has a minimal eﬀect on the
water acidity (Alpharma, 2001), although many authors
disagree. Therefore, it is prudent to consider buﬀering anaes-
thetic solutions, as MS-222 is typically acquired in acidic form
that can yield a pH as low as 2.8 in water, depending on the
water hardness and MS-222 concentration (Ohr, 1976). Acid-
ity results from the formation of methanesulfonic acid (Smith
et al., 1999). Under low pH conditions, disturbances in ﬁsh
ionic and osmotic balance can lead to haemoconcentration,
increased blood pressure and a suppressed metabolic rate
(Packer, 1979; Milligan and Wood, 1982; Iwama et al., 1989;
Burka et al., 1997; Pelster and Randall, 1998; Carter et al.,
2011). Although unbuﬀered MS-222 is acidic in aqueous
solutions, some authors dissolved it in ionized water or
dechlorinated tank water (Xu et al., 2008; Zahl et al., 2009).
Xu et al. (2008) investigated the eﬀects of buﬀered and
unbuﬀered MS-222 in dechlorinated tank water on the survival
and reproduction of a ﬁsh ectoparasite. A constant pH,
between 7.25 and 7.38, was maintained in the buﬀered
solution, whereas the pH of the unbuﬀered solution was
signiﬁcantly reduced. In a separate study Zahl et al. (2009)
dissolved MS-222 in ionised water and added the solution to
seawater tanks to evaluate anaesthesia on Atlantic cod (Gadus
morhua). Due to the buﬀering capacity of seawater, MS-222
induced only a minor pH reduction from 7.9 to 7.5. It would
thus appear that unbuﬀered MS-222 solutions have higher
safety margins in the seawater. Although saltwater and
freshwater with higher alkalinities contain a suﬃcient buﬀering
capacity to maintain an acceptable pH (Piper et al., 2001;
Carter et al., 2011), buﬀering protocols should be standar-
dised, both for experimental and practical farm purposes.
It is recommended that MS-222 be buﬀered with imidazole,
sodium hydrogen phosphate or sodium hydroxide (Brown,
1993; Davis et al., 2008). The most commonly used buﬀer is
sodium bicarbonate (NaHCO3), as a 1 : 2 ratio solution in
tank water (Kolanczyk et al., 2003; Pirhonen and Schreck,
2003; Wagner et al., 2003). Although there are literature
reports on the use of NaHCO3 in distilled water (Barreto et al.,
2007), the water used to anaesthetise ﬁsh should be taken from
the environment (aquarium, sea cage, tank); distilled or
deionized water should not be used, as neither possesses any
buﬀering capacity (Smit et al., 1977). Bicarbonate-neutralized
MS-222 at pH >7 results in faster (shorter induction time),
longer lasting and more consistent anaesthesia with reduced
recovery times (Ohr, 1976; Smit and Hattingh, 1979), while the
use of unbuﬀered MS-222 may cause serious epidermal and
corneal damage in ﬁsh (Davis et al., 2008). The American
Veterinary Medical Association (AVMA) recommends that
only solutions at or exceeding 500 mg ⁄ L need to be buﬀered
when euthanizing ﬁsh (AVMA, 2007).
Users of MS-222 are interested in methods of preparation
and storage of solutions for easier handling. The reported
shelﬂife of the substance after dilution or reconstitution varies
from 12 h (Pharmaq, 2010), 3–10 days (Western Chemical,
2008), one month (Alpharma, 2001), and up to 3 months (Ross
and Ross, 2008) if kept in a dark and cool place. The colour of
MS-222 solutions may change rapidly to yellow or brown
when exposed to light, which does not aﬀect its activity. A
10% solution stored at room temperature showed no signif-
icant loss of potency after 3 days, while a brownish colour and
an activity decrease of about 5% was observed after 10 days
(Western Chemical, 2008). In addition, the fate of the
substance in solution is poorly understood. Instructions to
discard stock solutions after several days are too vague to
interpret (Western Chemical, 2008; Argent, 2011). Further
studies are required, especially regarding the eﬀectiveness of
solutions in relation to temperature, salinity and light. Thus,
we recommend that solutions should be freshly prepared and
kept in dark glass bottles.
Anaesthetic efficacy and dosage
The eﬃcacy of MS-222 depends on environmental factors, i.e.
temperature, oxygen content, pH, hardness and salinity of
water, and biological factors such as age, sex, size, weight, lipid
content, ﬁsh species and density of biomass. Variations among
species, size, maturity, and between individual ﬁsh should be
considered when determining the dosage of the anaesthetic.
Although increased temperature has been reported to shorten
induction and recovery times in several teleost species (Hous-
ton and Woods, 1976; Sylvester and Holland, 1982; Hikasa
et al., 1986; Bowser, 2001; Zahl et al., 2009), the importance of
ﬁsh body size for the response to anaesthesia is less clear. Some
studies demonstrate no relationship between body size and
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induction and recovery time, whereas others suggest that such
a relationship does exist. Atlantic cod is an example of
increasing induction and recovery time with increasing weight
(Houston et al., 1976; Zahl et al., 2009). This suggests that the
rate of absorption of the anaesthetic in relation to weight is
slower in larger ﬁsh and may be a reﬂection of the smaller gill
surface area in relation to body mass as a smaller area is
available for drug diﬀusion relative to size. Regarding a
diversity of factors inﬂuencing MS-222 eﬃcacy with regard to
ﬁsh size, Son et al. (2001) showed that smaller black rockﬁsh
(Sebastes schlegeli) were less resistant to the chemical than
larger ﬁsh, although MS-222 eﬀects diﬀered with ﬁsh growth
history, as ﬁsh cultured in embanked populations showed
stronger resistance to anaesthetic stress, expressed in their
earlier recovery and lower mortality compared to those
cultured in land-based tanks or collected from wild stocks.
Further studies should be conducted in challenge experiments
in order to assess the size-related variations within ﬁsh species.
An additional aspect to consider in MS-222 eﬃcacy and
dosage determination is a potentially reduced time to anaes-
thesia following repeated exposure. Unfortunately, investiga-
tion of this eﬀect is rare. During weekly exposures in a study
by Smith et al. (1999), hybrid tilapias previously exposed to
MS-222 did not display a signiﬁcantly reduced time to
anaesthesia upon the second exposure, but did display
signiﬁcant reductions upon the third exposure and thereafter,
suggesting that they did not respond to MS-222 with the
typical enzyme induction-mediated tolerance reaction com-
monly observed with anaesthetics in mammals (Benson, 2002).
Another important factor aﬀecting xenobiotic ﬂux across the
dermal surface is the diﬀerence in skin anatomy in scaled and
scaleless ﬁsh. Trout skin, for example, is covered with scales
and has no taste buds. Catﬁsh skin, on the other hand, has no
scales and therefore these taste buds may oﬀer channels via
which chemicals can diﬀuse across the epidermis to the more
vascularised dermis (McKim et al., 1996). MS-222 is fat-
soluble, thus anaesthesia may last longer in larger or gravid
ﬁsh and recovery may be slower as the drug is removed from
the lipid reserves. Also, diseased or weakened animals are
much more susceptible to anaesthetic treatment (Coyle et al.,
2004). It is advisable to have ﬁsh fast for 12–24 h prior to
anaesthesia or sedation. An additional aspect to consider while
anaesthetising ﬁsh is their stocking density. Small variations in
stocking density impacted the eﬀectiveness of MS-222. Resis-
tance to the drug increased when the density of test ﬁsh was
increased from 0.3 to 0.9 g l)1 in rainbow trout (Oncorhynchus
mykiss), 0.4–1.2 g l)1 in carp (Cyprinus carpio), and
0.3–0.8 g l)1 in fathead minnows (Pimephales promelas) (Syl-
vester and Holland, 1982). Pharmaq (2010) recommends that
during treatment, ﬁsh should be stocked at a density not
exceeding 80 g l)1, although studies are warranted to assess
species-speciﬁc requirements. Due to the wide range of possible
factors aﬀecting its eﬃcacy, and the complicated synergistic
relationships among such factors, the speciﬁc applicative
eﬃcacy of MS-222 in a given host is often diﬃcult to predict.
Extensive literature data can be found on MS-222 usage on
foodﬁsh species, although little is available on its dosage for
ornamental ﬁsh (Ross and Ross, 2008; Weber et al., 2009; Zahl
et al., 2009).
Anaesthesia in ﬁsh can be divided into four stages (I-IV) and
eight categories: (i) normal behaviour with active swimming;
(ii) light sedation with slight loss of reactivity to visual and
tactile stimuli and normal respiratory rate; (iii) deep sedation
with cessation of voluntary swimming, and slight decrease of
respiratory rate (comprising stage I anaesthesia); (iv) light
narcosis where excitement phase may precede an increase in
respiratory rate; (v) deep narcosis with total loss of equilibrium
and slight reactivity to strong tactile and vibrational stimuli;
(vi) light anaesthesia (comprising stage II anaesthesia) with
further decrease in respiratory rate; (vii) surgical anaesthesia
(or stage III anaesthesia) with total loss of reactivity; and (viii)
medullary collapse with total loss of gill movement followed by
cardiac arrest (stage IV) (Brown, 1993; Coyle et al., 2004).
Although an aqueous solution of the substance prepared from
the powder form is most often used as an immersion bath for
temporary immobilisation, anaesthesia or sedation, large ﬁsh
such as sharks and rays have been anaesthetized by spraying
the gills with the MS-222 solution by means of a water pistol,
bulb syringe, hand-pump or similar (Western Chemical, 2008).
Before anaesthetising ﬁsh, it is recommended that the selected
drug concentration and exposure time be tested on a small
group of representative ﬁsh before medicating large numbers.
Doses for ﬁsh immersion are variable. A summary of studies
assessing dose ranges, induction and recovery times is
displayed in Table 1. The employed concentrations of MS-
222 depend on size and species of the ﬁsh and the reason for
sedation or anaesthesia, with exposure times ranging from a
few minutes for high concentrations and up to 48 h for low
concentrations. Recovery takes place after 1 to 60+ min, and
during this period ﬁsh should be closely observed. Under-
standing the relationship between dose, exposure time and
achieved anaesthetic stage ensures control of the procedure.
The degree and nature of analgesia achieved and the ease of
recovery are also important. Unfortunately, descriptions of
these features are rarely available.
Fish stress responses
Fish show external and internal signs of stress, which are
comparable to those described for higher vertebrates. Fish
experiencing severe acute stress develop a stress response in
which hormonal, biochemical, osmoregulatory, immune and
energetic alterations take place (Ribas et al., 2007). Severe or
chronic stress is often associated with poor performance and
has been associated with immunosuppression in cultured ﬁsh
(Iwama et al., 1989; Thomas and Robertson, 1991; Small,
2003; Palic et al., 2006).
The initial reaction to a stressful situation is associated with
an activation of the neuroendocrine systems, leading to the
release of hormones, i.e. catecholamines and corticosteroids.
Catecholamines are released into the circulation within
seconds following acute stress, though their concentration
drops rapidly. Corticosteroids are released more slowly than
the catecholamines, and elevated plasma levels return more
slowly to basal values. Measurements of cortisol are therefore
common in the assessments of the stress response in ﬁsh. An
elevated level of stress hormones leads to a faster ventilation
rate, increased branchial blood ﬂow and increased cardiac
output (Zahl et al., 2009). Along with cortisol, plasma glucose
and chloride are physiological variables that respond to
stressors, serving as indicators of the level of the stress
response (Wagner et al., 2002). A ﬁsh in a state of acute stress
anaesthetised through bath immersion will absorb the anaes-
thetic more rapidly and may also absorb a larger amount,
thereby obtaining faster induction, deeper anaesthesia and
delayed recovery (Zahl et al., 2009). Showing that the anaes-
thetics themselves may be stressors, Barton and Peter (1982)
established that a 15-min exposure to 50 mg l)1 MS-222
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induced a stress response in juvenile rainbow trout. Therefore,
MS-222 itself may act to increase cortisol levels, even when the
ﬁsh are not subjected to physical stressors (Strange and
Schreck, 1978; Davis et al., 1982; Small, 2003; Wagner et al.,
2003). MS-222 yielded a similar increase in the cortisol
concentration, as observed in ﬁsh exposed to handling and
crowding stress without an anaesthetic (Small, 2003; Palic
et al., 2006).
The slow induction of stage I anaesthesia during exposure to
MS-222 may provide time for the ﬁsh to detect the anaesthetic
agent due to its very distinctive chemical properties. It may be
sensed through taste and smell and may also act as a skin
irritant. Furthermore, as the anaesthetic starts to take eﬀect,
loss of balance may also elicit a stress response. Therefore, the
length of time needed to induce anaesthesia is of importance.
In both human and veterinary medicine, anaesthesia is often
preceded by administration of a sedative to calm the patient
and reduce any stress that might be caused by the anaesthetic
or the anaesthetic procedure. Such pre-anaesthesia sedation
has been tested with good results in several ﬁsh species,
including salmon, in an attempt to reduce the stress response
(EFSA, 2009a; Zahl et al., 2009, 2010).
The challenge is to establish a dosage of MS-222 that will
not act as a stressor, especially since it is often diﬃcult to
disassociate the handling response from the experimental
response. There is a also paucity of information regarding
cortisol response to MS-222 for aquarium ﬁsh. An inﬂuential
study (Crosby et al., 2006) on three-spot gourami
(Trichogaster trichopterus), a commonly cultured tropical
ornamental ﬁsh, evaluated plasma cortisol levels after handling
stress and treatment with MS-222 (60 mg l)1) where treated
ﬁsh had signiﬁcantly lower cortisol levels than untreated
controls. MS-222 was thus found to be beneﬁcial in reducing
handling stress of these obligate air breathers, which are
diﬃcult to sedate due to the labyrinth organ used for breathing
air at the waters surface that allows maintaining a high level of
activity in habitats with periodically low oxygen levels.
Effects on fish physiology and blood properties
The physiological consequences of MS-222 use have been well
documented. Several authors illustrated that MS-222 could
signiﬁcantly alter ﬁsh blood plasma chemistry (Gingerich and
Drottar, 1989; Harrington et al., 1991; Holloway et al., 2004).
It impacts circulatory changes in the secondary lamellae in the
form of vasodilatation and haemoconcentration (Soivio and
Hughes, 1978). Anaesthesia induced with MS-222 contributed
to hypoxemia, hypercapnia, respiratory acidosis and hyper-
glycemia in red pacu (Piaractus brachypomus) (Sladky et al.,
2001). Due to hypoxia during MS-222 anaesthesia, blood
glucose, lactate, potassium, sodium, magnesium, haemoglobin,
haematocrit and lysozyme activity, and erythrocyte swelling
have been reported to increase (Hattingh, 1977; Soivio et al.,
1977; Brown, 1993; Cho and Heath, 2000; Sladky et al., 2001;
Velisek et al., 2009). Urinary output and electrolyte loss also
increased (Brown, 1993), although this did not aﬀect post-
recovery plasma chloride concentrations (Small and Chatak-
ondi, 2005). Elevated plasma protein has also been associated
with MS-222 anaesthesia of rainbow trout (Laidley and
Leatherland, 1988). In gilthead seabream (Sparus aurata)
blood glucose levels of anaesthetised ﬁsh were signiﬁcantly
higher than those of control ﬁsh (Ortuno et al., 2002).
However, MS-222 had an inhibitory eﬀect on glucose release
in isolated hepatocytes from rainbow trout, likely due to
stress-induced inhibition of glycogenolysis (Puceat et al.,
1989).
Variability in blood chemistry highlights the importance of
knowing the eﬀect of the anaesthetic so as to not compromise
blood plasma measurements that are integral to the experi-
mental design. Suitable controls should thus be incorporated
into the research design involving MS-222, particularly when
variations in blood plasma chemistry parameters are being
used as dependent variables. Also, the degree of central
nervous system depression resulting from MS-222 use does not
necessarily mitigate certain physiological responses, and ﬁnd-
ings of various experiments should also be viewed in respect of
the dosage, exposure time, and phase of anaesthesia (induc-
tion ⁄ recovery). For example, Macavoy and Zaepfel (1997)
reported increased haematocrit during acid stress and that the
use of MS-222 to ease haematocrit sampling should not elevate
measurements. They showed that exposure of blacknose dace
(Rhinichtys atratulus) to 300 and 500 mg l)1 MS-222 did not
raise haematocrit levels above those of controls. However, they
collected blood samples only when ﬁsh attained the deepest
inductive state with relatively high doses of MS-222. Although
buﬀering of the anaesthetic solution is crucial regarding the
acidity of the water, it also inﬂuences the physiological
reaction to the anaesthetic. Administration of buﬀered
MS-222 reduced the blood pH of freshwater ﬁsh (Soivio et al.,
1977). When ﬁsh were anaesthetized with unbuﬀered solutions,
blood urea nitrogen concentrations, hypercholinesteremia and
ACTH production increased (Wedemeyer, 1970) whereas
glucose levels decreased (Soivio et al., 1977).
MS-222 reduced feed intake after anaesthesia in rainbow
trout. Non-anaesthetised ﬁsh ingested 15–20% more food than
MS-222 anaesthetised ﬁsh, for up to 48 h (Pirhonen and
Schreck, 2003). Application of MS-222 slightly altered internal
organs and tissues (brain, muscle, liver, intestine sections) of
rainbow trout, resulting in increased reactive oxygen species
formation and leading to oxidative damage to lipids and
proteins and the inhibition of antioxidant capacities (Velisek
et al., 2011).
This anaesthetic reduced the contractile force of paced strips
of the ventricular myocardium by almost 75% (Hill et al.,
2002). During myography, it blocked vagal nerve transmission
to the heart for Chinook salmon (Oncorchynchus tshawytcha)
(at 100 mg l)1) and caused a 30–40% dilation of eﬀerent and
aﬀerent branchial arteries (Hill et al., 2002). Heartbeat and
respiratory frequency measurements of common carp exposed
to concentrations of 75, 100, 125, 150 mg l)1 revealed a
concentration eﬀect, with a similar recovery time in all
treatments (Dziaman et al., 2005). Compared to unanaesthe-
tized rainbow trout of variable size and similar water temper-
ature, the heart rate was higher for trout exposed to S-222,
which is consistent with parasympathetic inhibition in teleosts
(Cotter and Rodnick, 2006). MS-222 anaesthesia in rainbow
trout produced cardioacceleration followed by prolonged
bradycardia. Cardioacceleration was found to be due to
catecholamine release caused by the stress of exposure, and
bradycardia was found to be produced by an increase in vagal
tone caused by anoxia. All cardiac rates returned to normal
within 8 h after removal from the anaesthetic solution
(Lochowitz et al., 1974). Fredericks et al. (1993) reported that
exposure of rainbow trout to MS-222 produced only minimal
cardiovascular alterations, and that the mean dorsal aortic
pressure decreased during exposure, whereas the heart rate and
EKG patterns rapidly returned to normal. Depressed respira-
tion, in combination with changes in blood oxygen and carbon
Tricaine methane-sulfonate (MS-222) application 15
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dioxide levels, can cause changes to the heart rate and cardiac
output, therefore it is important to aerate both induction and
recovery baths (Carter et al., 2011).
Pharmacokinetics following bath administration
In order to establish correct dosage regimes and thereby
promote optimal use, data derived from pharmacokinetic
investigations are vital. Studies of elimination kinetics are also
necessary in order to determine withdrawal times for drugs
used in the production of food for human consumption
(Kiessling et al., 2009). Absorption and elimination of MS-222
occurs by diﬀusion across the gill membranes (Wayson et al.,
1976). Although eliminated primarily as the unmetabolized
parent chemical, biotransformation to hydrolysis and acety-
lated products was noted (Kolanczyk et al., 2003). In adult
spiny dogﬁsh (Squalus acanthias) two major biotransformation
pathways have been identiﬁed for MS-222. One pathway
involved the hydrolysis of the ethyl group of MS-222 (the
methane sulphonic acid salt of ethyl-m-aminobenzoate) to
yield m-aminobenzoic acid followed by acetylation of the
amine group to produce m-acetylaminobenzoic acid (Stenger
and Maren, 1974). The second pathway involved the acetyla-
tion of the amine group to yield ethyl-m-aminobenzoate
followed by hydrolysis of the original acetyl group to generate
m-acetylaminobenzoic acid as the end product. These
biotransformations occurred in liver and gills. In adult
rainbow trout, MS-222 and ethyl-m-acetylaminobenzoate are
excreted mainly via the kidney, while potencies of the
metabolites of MS-222 have not been determined (Hunn
et al., 1968). More recent ﬁndings speculate that none of the
identiﬁed metabolites of the compound was pharmacologically
active (EMEA, 1999). Based on literature data, if MS-222 is
less toxic ⁄ eﬀective than its metabolites, increased sensitivity
with age could be explained by an increase in the activity of
biotransformation pathways. Alternatively, if MS-222 were
more toxic, one would need to evoke a decrease in the activity
of biotransformation pathways to explain increased sensitivity
with age (Rombough, 2007).
MS-222 was rapidly eliminated from Atlantic salmon
(Salmo salar) plasma, while artiﬁcial ventilation during recov-
ery increased the rate of elimination during the ﬁrst 5-8 min
before regaining respiration. Elimination of MS-222 was
directly related to its water-soluble properties, indicating that
this is an important factor to consider when setting withdrawal
times (Kiessling et al., 2009). Also, MS-222 decreased the
uptake of lipophilic compounds administered to ﬁsh (Sijm
et al., 1993). Thus, its use has to be considered in certain trials
since experimental methods signiﬁcantly aﬀected the pharma-
cokinetic variables that are used to model the bioconcentration
of hydrophobic chemicals in the environment.
Potential interference of MS-222 upon hepatic cytochrome
P-450 spectra
Metabolism, or the biotransformation of certain foreign
hydrophobic compounds, including many therapeutic agents
and environmental pollutants, is generally an enzymatic
process. P-450 enzymes (P450) play important roles in the
oxidation of structurally diverse chemicals. Multiple forms of
P450s existing in ﬁsh hepatic microsomes exhibit typical
reduced CO absorption spectra, with a peak near 450 nm.
Reports on the eﬀects of MS-222 on spectral measurements of
hepatic microsomal cytochrome P450 are conﬂicting (Chevion
et al., 1977; Fabacher, 1982; Kleinow et al., 1986). The
MS-222 immersion overdose, although resulting in unambig-
uous immunoblots and catalytic activity, revealed atypical
P450 spectra in the hepatic microsomes of summer ﬂounder
(Paralichtys dentatus) and hybrid striped bass (Morone saxa-
tilis · M. chryops). The vast majority of microsomes exhibited
average maxima of 422 nm (personal data). According to
Arinc and Sen (1994), a possible cause for the signiﬁcant
decrease of the cP450 content and activities may be anaesthesia
of ﬁsh prior to removing livers for analysis, as in vivo
benzocaine treatment decreased liver microsomal aniline
4-hydroxylase activity of gilthead seabream by 57%. When
brook trout were exposed to a water solution of MS-222 for
5 min, BP hydroxylase activity and cytochrome level were
inhibited by 78 and 28%, respectively. Kolanczyk et al. (2003)
noted slight decreases in P450 levels following 2 h exposure of
trout to 100 mg l)1 MS-222. Although not signiﬁcant, they
attributed this diﬀerence to P450 chemical interaction with
MS-222, resulting in type II binding spectra, where the
chemical bonds with the heme iron of cytochrome P450, and
the spectrum shows a trough at 408 nm and peak at 428 nm.
Thus, MS-222 may inﬂuence the production of atypical P450
spectral measurements, which may have implications on P450
activity.
Effects on nerve sensitivity
Initially, absorption of MS-222 is rapid across the gills and
quickly penetrates into the central nervous system (CNS),
where it has an immediate eﬀect on the autonomic nervous
system to produce a form of vagus escape (Treves-Brown,
2000). In ﬁsh, it produces general anaesthesia and inhibits
neural signal transmission ranging from the periphery to
higher parts of the nervous system. Although it has been
suggested (Frazier and Narahashi, 1975; Neumcke et al., 1981;
Arnolds et al., 2002) that the physiological eﬀects of MS-222
on individual supramedullary ⁄ dorsal neurons are based on
blocking sodium channels, its mechanism at the CNS level is
not fully understood (Hara and Sata, 2007; Ueta et al., 2007).
Critical drug concentrations are reached more rapidly with
higher anaesthetic exposure levels, thus supporting the
hypothesis that simple diﬀusion and osmotic pressure are
principally responsible for the rapid uptake of MS-222 in
snapper (Pagrus auratus). Loss of voluntary movement in
snapper was dependent on the levels of anaesthetics in the
blood and brain, implying that the eﬀects of MS-222 were not
only peripheral in the sodium channel (Ryan, 1992).
MS-222 had suppressive eﬀects on peripheral and central
neurons in acute preparations of numerous sensory systems,
including electroreceptors, supramedullary ⁄ dorsal neurons
and the lateral line (Palmer and Mensinger, 2004). The lateral
line system provides a good model to determine the eﬀects of
anaesthesia on nerve excitability, since lateral line hair cells can
be physiologically characterized and easily excited by external
stimuli. Palmer and Mensinger (2004) showed that the damp-
ening eﬀect of MS-222 on the ﬁring activity of the lateral line
nerve is demonstrated by an increase in the interspike interval
in response to increasing anaesthesia. Based on a study on the
use of MS-222 during evoked potential audiometry in goldﬁsh
(Carassius auratus) (Cordova and Braun, 2007), it appeared
that brief sedation (<10 min) did not alter auditory sensitiv-
ity. Also, since lower concentrations of MS-222 did not
suppress ﬁring in lateral line nerve ﬁbres (Palmer and
Mensinger, 2004), it may not be necessary to wait long periods
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of time following brief MS-222 anaesthesia before initiating an
auditory-evoked potential. MS-222 signiﬁcantly altered aﬀer-
ent input, spike height and the current needed to elicit an
action potential of supramedullary ⁄ dorsal cells. Therefore,
neurophysiological measurements must be interpreted with
caution if MS-222 is used as a general anaesthetic. Zottoli
et al. (2003) tested whether MS-222 aﬀected physiological
parameters of neurons having somata within the CNS. The
transient use of MS-222 and the removal of the telencephalic
hemispheres in that study had no residual eﬀect on spike
height, the current needed to elicit an action potential, or the
ability to elicit post-synaptic potentials from the supramedul-
lary ⁄ dorsal cells. Thus, the authors concluded that the
transient use of MS-222 followed by removal of the telen-
cephalon served as a reasonable precaution against the
possibility that ﬁsh experience pain. There are opposing
opinions as to whether ﬁsh experience pain, suggesting that
there is an important diﬀerence between knowledge about
sensation and sentience (EFSA, 2009b). Although the concept
of pain in ﬁsh is still a matter of controversy, it is widely
accepted that that they have the capacity for fear and suﬀering,
possessing the same types of specialized receptors as birds and
mammals that allow the detection of noxious stimuli (noci-
ceptors). The area of pain perception and the eﬀect of MS-222
would greatly beneﬁt with novel data to bolster scientiﬁc
understanding on the subject (Braithwaite and Boulcott, 2007;
Rose, 2008; Ross and Ross, 2008). Research and developments
in the area of cognition and brain imaging techniques in ﬁsh
should be carried out to further the knowledge and under-
standing of pain perception, and the potential of anaesthesia to
modulate nociception.
Immune response and genotoxicity
Anaesthesia may have immunodepressive eﬀects in mammals;
however, few authors have attempted to detect anaesthesia-
induced immunodepression in ﬁsh (Ortuno et al., 2002).
Circulating leucocyte counts are often used to assess the
immunological health of ﬁsh. Speciﬁc changes were found in
gilthead seabream anaesthetized with MS-222 in transport
simulation (Cubero and Molinero, 1997), i.e. in the basophilic
percentage drop, delay in acidophilic and basophilic response,
and lymphoctopenia in thymus and pronephros. In a separate
study on the same species, neither humoral nor cellular
immune responses were depressed by MS-222 (Ortuno et al.,
2002). The authors speculated that the reason that MS-222 did
not depress haemolytic complement activity and phagocytic
activity or inﬂuence respiratory burst activity of head-kidney
leucocytes could be related to the dosage of the anaesthetic
and ⁄ or its mode of action. Although the reason for the lack of
immunodepression (which was demonstrated with three other
investigated anaesthetics) was not elucidated, the authors
suggested that it might be related to the direct interaction
between the anaesthetic and immune components independent
of stress signals. Further study is required to understand these
observations and assess the possibilities of MS-222 induced
immunodepression.
Erythrocytes are used as standard sentinel markers of
genotoxic exposure in ﬁsh. The single cell gel comet assay
was employed to assay MS-222 genotoxic eﬀects on Nile
tilapia (Oreochromis niloticus L.) erythrocytes (Barreto et al.,
2007). No direct genotoxic activity was induced by MS-222
under either in vivo or in vitro conditions. Erythrocytes did not
have DNA damage following in vivo bath exposure of ﬁsh to
MS-222. Similarly, in vitro treatments of erythrocytes with
increasing doses of MS-222 did not induce a signiﬁcant
increase of DNA damage. No cytotoxicity was found follow-
ing in vivo or in vitro MS-222 exposure. Other procaine
analogues, typically used as local anaesthetics in humans, have
tested negative for genotoxicity in diﬀerent organisms, and
therefore the authors suggested MS-222 to be a safe anaes-
thetic for use on ﬁsh (Barreto et al., 2007). However, further
tests will be needed to explore the possible co-genotoxic eﬀects
of MS-222 in association with other genotoxins.
MS-222 could be used on ﬁsh prior to gamete harvesting
without signiﬁcant adverse impacts on gametes. Exposure of
steelhead trout (Oncorhynchus mykiss) unfertilized eggs for 6
or 24 h to 225 mg l)1 MS-222 resulted in no reduction in egg
fertility or embryo survival to hatch. However, higher doses
reduced egg quality. Similarly, 3 h exposure to MS-222
(225 mg l)1) produced no signiﬁcant eﬀect on sperm motility
in steelhead trout (Holcomb et al., 2004; Zydlewski et al.,
2008). While anaesthesia had no impact on egg survival, in
anaesthetised males direct contact between MS-222 and sperm
aﬀected the duration of sperm motility (Wagner et al., 2002).
In a hatchery where MS-222 is to be used on broodstock, the
general practice should be to dip the anaesthetized ﬁsh into a
container of clean water prior to spawning to wash oﬀ residual
anaesthetic that might interfere with fertilization.
Fish euthanasia
Euthanasia of both wild and captive ﬁsh is a common
requirement in aquaculture and ﬁsheries research for the lethal
collection of tissues and blood. If a ﬁsh has to be killed, then
death must occur with the least possible anxiety, pain and
distress. MS-222 oﬀers an alternative to other means of
chemical or physical ﬁsh euthanasia, but is not permitted for
use prior to slaughter for any purpose on any ﬁsh that might
enter the food chain (EFSA, 2004). A concentration of
250 mg l)1 is the minimal concentration suggested by the
AVMA for euthanasia of amphibians and ﬁsh (AVMA, 2007).
A lethal dose of 400–500 mg l)1 is generally used for eutha-
nasia of salmonids (Ackerman et al., 2005). For euthanasia,
MS-222 is commonly used unbuﬀered (Callahan and Noga,
2002). In order to establish the most appropriate method for
zebraﬁsh (Danio rerio) euthanasia, both buﬀered and unbuf-
fered solutions were used (Wilson et al., 2009). When unbuf-
fered MS-222 was used to euthanize zebraﬁsh, signs of distress
occurred in 100% of ﬁsh with rapid opercular movements,
with 39% exhibited piping behaviour (gulping of air at the
water surface). None of the animals exposed to the buﬀered
MS-222 displayed rapid opercular movements. Interestingly,
for 2 min past the last observable opercular movement, a
signiﬁcant number (17.4%) of zebraﬁsh exposed to unbuﬀered
solution regained consciousness in the recovery tank. This
ﬁnding suggests a need for closer monitoring when euthanizing
animals. Indeed, few studies describe dose-response testing and
reliability of euthanasia in diﬀerent species.
In order for an overdose of anaesthetic to be a reliable and
humane killing method for ﬁsh, more knowledge is needed
before recommending the minimum dosage and exposure
times for speciﬁc life stages, body sizes and water tempera-
tures. Such information would help to ensure a minimum time
to loss of consciousness and minimum induction of stress
(EFSA, 2009a). Since stage III anaesthesia generally involves a
cessation of breathing, which reduces gas transfer leading to
hypoxia, respiratory acidosis and stress responses, prolonged
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maintenance of stage III anaesthesia without gill irrigation will
result in death. Within that context, ﬁsh handlers should be
concerned with the welfare of animals, as deﬁned by the World
Organisation for Animal Health (OIE). Good animal welfare
requires, amongst other necessities, the humane handling and
killing of ﬁsh (OIE Resolution, Article 7.1.1.). Fish welfare,
however, has not been studied to the same extent as terrestrial
farm mammals and birds, and neither welfare concepts nor
welfare needs are clearly understood in the diﬀerent ﬁsh
species. For this reason, conscientious, good laboratory
practice is always recommended when euthanizing ﬁsh with
MS-222. For this method to be reliable, eﬀective, and humane,
the technical competence of the staﬀ involved is paramount in
all aspects of euthanasia.
Concluding remarks
Research to date has provided an abundance of data on MS-
222 usage in ﬁsh, although applications within these studies are
often impractical at the farming level. Future eﬀorts should be
expanded to include studies on important farmed species (both
marine and freshwater species, and ornamental ﬁsh), other
than rainbow trout, as the present data are mainly the result of
studying the eﬀects of MS-222 on rainbow trout. Likewise,
research is also needed on the use of MS-222 in juvenile ﬁsh, a
critical period in the life cycle, as most MS-222 studies have
been conducted on adult ﬁsh. In order to increase the eﬃciency
and safety of this compound, several key issues should be
highlighted and future perspectives recommended:
• MS-222 users, particularly in Europe, should follow
updated regulations relating to the legal aspects of the
methods and safety of its use in their countries, since this
anaesthetic is not licensed in all countries. Also, there are
diﬀerences regarding the permitted application purpose and
withdrawal times. These legislative topics are a matter of
high priority, and a common act should be suggested to
decrease inconsistencies within the countries of a region.
• It is suggested that MS-222 solutions be buﬀered; although
unbuﬀered solutions have higher safety margins in seawa-
ter, it was shown that this anaesthetic increased the acidity
of the water. Buﬀering protocols need to be standardized,
both for experimental and practical farm purposes. Further
research is necessary on the possibilities of preparation and
storage of solutions for easier administration, particularly
for ﬁeld studies.
• Safety margins, induction and recovery times for many ﬁsh
species still need to be established and doses need to be
recommended. Due to the wide range of possible factors
aﬀecting MS-222 eﬃcacy, and their synergistic relation-
ships, deﬁnition of its speciﬁc applicative eﬃciency for
various species and various life stages is a challenging task.
• Although MS-222 anaesthesia beneﬁts the ﬁsh by mini-
mising the impact of a greater, more severe stressor, it is
nonetheless stressful and the physiological eﬀects on the
stress response associated with MS-222 anaesthesia must be
recognized.
• Substantial research has been conducted on the eﬀects of
this anaesthetic on ﬁsh physiology and blood properties,
and an array of MS-222-induced changes has been
documented. Caution should be exercised in research
applications, since its eﬀects on blood plasma hormones
have not been adequately investigated in marine species.
When comparing the results of variations in blood plasma
chemistry between laboratories, care should be taken
regarding the protocol of anaesthetisation so as not to
compromise the physiological and blood plasma measure-
ments integral to the experimental design.
• Pharmacokinetic investigations and elimination kinetic
studies are needed to establish the correct dosage regimes
and withdrawal times for diﬀerent species. Also, the
possible interference of MS-222 on the ﬁsh cytochrome
P450 spectrum should be incorporated into trials due to its
possible implications on P450 activity.
• Although the physiological eﬀects of MS-222 on individual
supramedullary ⁄ dorsal neurons are based on the blocking
of sodium channels, its mechanism at the CNS level is not
fully understood. Studies are required to assess the potential
of MS-222 to induce immunodepression.
• Staﬀ administering this anaesthetic should fully comply
with the anaesthetization protocol, and preliminary tests
should be performed with small numbers of ﬁsh in order to
prevent accidental overdose. The desired level of anaesthe-
sia should be controlled, all netting performed carefully,
handling time reduced to a minimum, and ﬁsh behaviour
and breathing rate monitored as they go through the
various stages of anaesthesia. Technical competence of staﬀ
is vital.
Since anaesthetics administered to ﬁsh through bath immer-
sions are equivalent to inhalation anaesthesia in human and
veterinary medicine, when choosing the anaesthetic for a
variety of potential uses on ﬁsh, one has to consider several of
its properties such as eﬀectiveness, safety for the ﬁsh, safety for
the user and environment, eﬀects on physiological and blood
properties, stress induction, convenience of use, the nature of
investigated experimental protocols and costs. Although
MS-222 is relatively expensive, the beneﬁcial characteristics
will ensure its continuous application in aquaculture, whether
for research, food production or ornamental ﬁsh rearing.
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